| Monahan
Lab

Paul
E. Monahan, MD
Associate
Professor, Department of Pediatrics,
Division of Hematology/Oncology
Attending Physician, Comprehensive Hemophilia Diagnostic and
Treatment Center; University of North Carolina at Chapel Hill,
N.C.
MD, University of Virginia School of
Medicine
Laboratory
phone: 919.843.4984
monoman@med.unc.edu
Publications:
- Monahan PE. The expanding menagerie: animal models of hemophilia A. J Thromb Haemost. 2010 Nov;8(11):2469-71. doi: 10.1111/j.1538-7836.2010.04053.x. No abstract available. PMID: 21251193
- Monahan PE, Di Paola J. Recombinant factor IX for clinical and research use. Semin Thromb Hemost. 2010 Jul;36(5):498-509. Epub 2010 Jul 14.
- Monahan PE, Sun J. Hemophilic synovitis: Factor VII and the potential role of extravascular factor VIIa. Thromb Res. 2010. Apr;125 Suppl 1:S63-6.
-
Monahan PE, Liesner R, Sullivan ST, Ramirez ME, Kelly P, Roth DA. Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B. Haemophilia. 2010 May; 16(3):460-8.
- Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci USA. 2009 Nov 3;106(44):18786-91.
- Gui T, Reheman A, Ni H, Gross PL, Yin F, Monroe D, Monahan PE, Stafford DW. Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV. J Thromb Haemost. 2009 Nov;7(11):1843-51.
- Weston BW, Monahan PE. Familial deficiency of vitamin K-dependent clotting factors. Haemophilia. 2008 Nov;14(6):1209-13.
- Monahan PE. Factor IX: Insights from knock-out and genetically engineered mice. Thromb Haemost. 2008 Oct;100(4):563-75.
-
Sun
J, Hakobyan N, Valentino LA, Feldman BL, Samulski RJ,
Monahan PE. Intra-articular
factor IX protein or gene replacement protects against
development of hemophilic synovitis in the absence of
circulating factor IX. Blood . 2008 Aug 20. [Epub ahead
of print]
-
Bhangoo
S, Ren D, Miller RJ, Henry KJ, Lineswala J, Hamdouchi
C, Li B, Monahan PE, Chan DM, Ripsch MS, White FA.Delayed
functional expression of neuronal chemokine receptors
following focal nerve demyelination in the rat: a mechanism
for the development of chronic sensitization of peripheral
nociceptors. Mol Pain . 2007 Dec 12; 3: 38.
-
Kravtsov
DK, Monahan PE, Gailani D. A classification system
for crossreactive material negative factor IV deficiency. Blood,2005, prepublished online February 22, 2005
.
-
Schrijver I, Hong DW, Mandle L, Jones CD, DiMichele D, Monahan PE, Zehnder JL. High frequency of premature termination mutations in the factor V gene: Three factor V deficiency case reports and a mutation review. Thrombosis and Haemostasis,2005
93(3):610-1.
-
Monahan
PE, Aledort LM, Hemophilia Inhibitor
Study Group, Factors affecting choice of treatment agent for patients with hemophilia and inhibitor antibodies.American Journal
of Hematology, 2004, 77:346-350.
-
Van
Cott KE, Monahan PE, Nichols T, Velander WH, Hemophilic factors produced by transgenic livestock: Abundance that can enable alternative therapies. Haemophilia,
2004, 10(s4):70-76.
-
Jin
D-Y, Zhang T-P, Gui T, Stafford DW, Monahan PE. Creation of a mouse expressing defective human factor IX. . Blood, 2004, 104(6):1733-1739.
-
Douvas
MG, Monahan PE. Life-threatening thrombosis complicating the management of hepatic hemorrhage: anticoagulant treatment in a newborn with hemophilia B. Journal of Pediatric Hematology/Oncology, 2004, 26(4):258-263.
Personnel
| Tong Gui |
David Wichlan |
| Genlin Hu |
Nattee Narkbunnam |
| Junjiang Sun |
|
|